Skip to main content
Midas Edge

SeaStar Medical Holding Corp

For the period ended Sep 30, 2025. Filed Nov 13, 2025.

View on SEC.gov

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Sep 30, 2025 · Filed Nov 13, 2025

ICU$1.90-3.1%Stored close · as of Nov 10, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits
Contents

Condensed Consolidated Statements of Operations (Unaudited)

Condensed Consolidated Statements of Operations

Three Months Ended September 30,Nine Months Ended September 30,
2025202420252024
Net revenue$183$68$814$68
Cost of goods sold14—41—
Gross profit1696877368
Operating expenses
Research and development1,8502,3365,3186,367
General and administrative1,8982,1884,6146,776
Total operating expenses3,7484,5249,93213,143
Loss from operations(3,579)(4,456)(9,159)(13,075)
Other income (expense)
Interest income1075820082
Interest expense—(272)(18)(497)
Other financing costs——(298)—
Change in fair value of convertible notes———(6,145)
Change in fair value of warrants liability—19232(773)
Total other income (expense), net107(22)(84)(7,333)
Loss before provision for income taxes(3,472)(4,478)(9,243)(20,408)
Provision for income taxes——33
Net loss$(3,472)$(4,478)$(9,246)$(20,411)
Net loss per share of common stock, basic and diluted$(0.13)$(1.10)$(0.60)$(6.10)
Weighted-average shares outstanding, basic and diluted26,393,4004,086,87115,512,1193,348,490
ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.